Cerebral Oxygenation and Autoregulation in Preterm Infants
Early NIRS
1 other identifier
observational
111
1 country
7
Brief Summary
Premature infants are at high risk for variations in blood pressure and oxygenation during the first few days of life. The immaturity of the premature brain may further predispose these infants to death or the development of neurologic problems. The relationship between unstable blood pressure and oxygen levels and brain injury has not been well elucidated. This study investigates the utility of near-infrared spectroscopy (NIRS), a non-invasive oxygen-measuring device, to identify preterm infants at highest risk for brain injury or death.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2014
Longer than P75 for all trials
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2014
CompletedFirst Submitted
Initial submission to the registry
May 21, 2014
CompletedFirst Posted
Study publicly available on registry
May 28, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2018
CompletedResults Posted
Study results publicly available
April 7, 2020
CompletedApril 7, 2020
April 1, 2020
3.6 years
May 21, 2014
March 21, 2020
April 5, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Mortality Before Hospital Discharge
Participants will be followed for the outcome of death prior to hospital discharge.
Outcome measure will be assessed at the time of subject's initial discharge from the hospital (on average by 40 weeks postmenstrual age), but at a maximum of 1 year of life.
Severe Central Nervous System (CNS) Morbidity
Routine cranial ultrasound obtained within the first ten days of life will be utilized to detect grade 3 or 4 intraventricular hemorrhage, periventricular leukomalacia, significant ventriculomegaly, or white matter abnormalities.
Outcome measure will be assessed on day 10 of life. Participants will be followed for neuroradiographic evidence of CNS morbidity in the first ten days of life
Study Arms (1)
Preterm infants monitored with NIRS
All infants enrolled in the study will be monitored with cerebral near-infrared spectroscopy (NIRS monitoring) to measure cerebral oxygenation levels in the first 96 hours of life. Mean arterial blood pressure will simultaneously be monitored.
Interventions
All enrolled infants will undergo NIRS monitoring of cerebral oxygenation in addition to monitoring of continuous arterial blood pressure.
Eligibility Criteria
All inborn preterm infants with birth weight \<=1250 grams and with an indwelling arterial catheter already in place are eligible for study enrollment if they are \<24 hours old at the time of enrollment. These preterm infants are at risk for impaired cerebral autoregulation and may undergo non-invasive monitoring of cerebral oxygenation using near-infrared spectroscopy (NIRS).
You may qualify if:
- inborn
- birth weight \<= 1250 grams
- indwelling arterial catheter in place
- age \<24 hours old
You may not qualify if:
- lethal chromosomal abnormality
- major congenital anomaly
- skin integrity insufficient to allow placement of NIRS sensors
- decision to not provide full intensive care
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Stanford Universitylead
- Medtronic - MITGcollaborator
Study Sites (7)
University of Alabama
Birmingham, Alabama, 35249, United States
Stanford University
Palo Alto, California, 94304, United States
Santa Clara Valley Medical Center
San Jose, California, 95128, United States
Yale-New Haven Children's Hospital
New Haven, Connecticut, 06520, United States
St. John's Children's Hospital
Springfield, Illinois, 62702, United States
Nationwide Children's Hospital
Columbus, Ohio, 43205, United States
UT Southwestern Medical Center
Dallas, Texas, 75390, United States
Related Publications (6)
Verhagen EA, Hummel LA, Bos AF, Kooi EM. Near-infrared spectroscopy to detect absence of cerebrovascular autoregulation in preterm infants. Clin Neurophysiol. 2014 Jan;125(1):47-52. doi: 10.1016/j.clinph.2013.07.001. Epub 2013 Aug 22.
PMID: 23973384BACKGROUNDAlderliesten T, Lemmers PM, Smarius JJ, van de Vosse RE, Baerts W, van Bel F. Cerebral oxygenation, extraction, and autoregulation in very preterm infants who develop peri-intraventricular hemorrhage. J Pediatr. 2013 Apr;162(4):698-704.e2. doi: 10.1016/j.jpeds.2012.09.038. Epub 2012 Nov 6.
PMID: 23140883BACKGROUNDSoul JS, Hammer PE, Tsuji M, Saul JP, Bassan H, Limperopoulos C, Disalvo DN, Moore M, Akins P, Ringer S, Volpe JJ, Trachtenberg F, du Plessis AJ. Fluctuating pressure-passivity is common in the cerebral circulation of sick premature infants. Pediatr Res. 2007 Apr;61(4):467-73. doi: 10.1203/pdr.0b013e31803237f6.
PMID: 17515873BACKGROUNDWong FY, Silas R, Hew S, Samarasinghe T, Walker AM. Cerebral oxygenation is highly sensitive to blood pressure variability in sick preterm infants. PLoS One. 2012;7(8):e43165. doi: 10.1371/journal.pone.0043165. Epub 2012 Aug 14.
PMID: 22905222BACKGROUNDCaicedo A, De Smet D, Naulaers G, Ameye L, Vanderhaegen J, Lemmers P, Van Bel F, Van Huffel S. Cerebral tissue oxygenation and regional oxygen saturation can be used to study cerebral autoregulation in prematurely born infants. Pediatr Res. 2011 Jun;69(6):548-53. doi: 10.1203/PDR.0b013e3182176d85.
PMID: 21364491BACKGROUNDWong FY, Leung TS, Austin T, Wilkinson M, Meek JH, Wyatt JS, Walker AM. Impaired autoregulation in preterm infants identified by using spatially resolved spectroscopy. Pediatrics. 2008 Mar;121(3):e604-11. doi: 10.1542/peds.2007-1487. Epub 2008 Feb 4.
PMID: 18250118BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Valerie Chock, MD
- Organization
- Stanford University
Study Officials
- PRINCIPAL INVESTIGATOR
Valerie Chock, MD
Stanford University
- PRINCIPAL INVESTIGATOR
Krisa Van Meurs, MD
Stanford University
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle Investigator
Study Record Dates
First Submitted
May 21, 2014
First Posted
May 28, 2014
Study Start
May 1, 2014
Primary Completion
December 1, 2017
Study Completion
March 1, 2018
Last Updated
April 7, 2020
Results First Posted
April 7, 2020
Record last verified: 2020-04